Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

9.4K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.4K
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

1.1K
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
1.1K
Study Design in Statistics01:15

Study Design in Statistics

10.4K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
10.4K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.7K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.7K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

387
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
387
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

580
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
580

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three-Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN-ON MED.

Journal of the American Heart Association·2026
Same author

Telomere length dynamics do not predict subclinical atherosclerosis progression over a six-year period.

GeroScience·2026
Same author

Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: primary results of the ARCHER study.

ESC heart failure·2026
Same author

Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL Trial.

Circulation·2026
Same author

Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction.

European heart journal·2025
Same author

Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial.

Heart (British Cardiac Society)·2025

Related Experiment Video

Updated: Apr 17, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Covariate adjustment in randomized trials: An overview.

Stuart J Pocock1

  • 1Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.

Clinical Trials (London, England)
|April 16, 2026
PubMed
Summary

Adjusting for prognostic covariates in randomized clinical trials can modestly increase statistical power. This overview covers methods, outcomes, and regulatory guidance for effective covariate adjustment.

Keywords:
Covariate adjustmentefficiency gainexamples in cardiovascular trialsguidelinesrandomized clinical trialstatistical methods

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K

Related Experiment Videos

Last Updated: Apr 17, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Statistical Power Analysis

Background:

  • Covariate adjustment is crucial in randomized clinical trials (RCTs) for enhancing precision.
  • Methods vary depending on outcome type (quantitative, binary, time-to-event).
  • Understanding the impact of adjustment on statistical power and regulatory compliance is essential.

Purpose of the Study:

  • To provide a practical overview of covariate adjustment methods in RCTs.
  • To offer recommendations for future clinical trial practices.
  • To evaluate the gains in statistical power achieved through covariate adjustment.

Main Methods:

  • Review of analysis of covariance for quantitative outcomes.
  • Examination of covariate adjustment across different outcome types.
  • Simulation study to quantify statistical power gains.
  • Survey of covariate adjustment practices in published trials.
  • Analysis of regulatory guidance on covariate adjustment.

Main Results:

  • Modest gains in statistical power are achieved by adjusting for covariates that influence prognosis.
  • The utility of center-adjusted analyses is evaluated.
  • Alternative covariate adjustment approaches are briefly discussed.

Conclusions:

  • Covariate adjustment, particularly for prognostic factors, is a valuable tool in RCTs.
  • Recommendations are provided for best practices in future clinical trials.
  • The strategic use of covariates, including for risk models, is highlighted.